Siolta Therapeutics
Early stage, venture-backed biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€136m (Public information from Mar 2024)
San Carlos California (HQ)
Authorizing premium user...